CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for KeraVision, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

KeraVision, Inc.
48630 Milmont Drive
Phone: (510) 353-3000p:510 353-3000 Fremont, CA  94538  United States Ticker: KERAKERA

This company's Plan of Liquidation went into effect on 5/21/2007
This company is no longer actively traded on any major stock exchange.

Business Summary
KeraVision, Inc. developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia (nearsightedness), hyperopia (farsightedness) and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on the Company's proprietary patented technology, has been approved by the Food and Drug Administration for correcting mild myopia. Intacs are designed to permanently correct a patient's vision while providing the option of removability. The placement of Intacs is a simple, minimally invasive procedure that can be performed on an outpatient basis typically in 15 minutes or less. In March 2001, the Company filed for protection pursuant to Chapter 11 of the United States Bankruptcy Code.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/200012/31/2000-YesYes--

Industries
SIC Code Description
3851 Ophthalmic goods

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Vice President, Manufacturing Robert P.Wood 41 4/1/1996 4/1/1996
Vice President - Europe DavidHeniges 56 7/1/1998 7/1/1998
Vice President - Quality Assurance Richard J.Meader 61 9/1/1998 9/1/1998
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 172 (As of 12/31/1999)
Outstanding Shares: 18,898,024 (As of 11/3/2000)
Shareholders: 500
Stock Exchange: OTC
Federal Tax Id: 770328942
Fax Number: (510) 353-3030


Copyright © 2021 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, November 8, 2021